QTS Stock Overview
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
IQVIA Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$217.10 |
| 52 Week High | US$238.00 |
| 52 Week Low | US$159.80 |
| Beta | 1.52 |
| 1 Month Change | -6.02% |
| 3 Month Change | 10.54% |
| 1 Year Change | 19.55% |
| 3 Year Change | 11.85% |
| 5 Year Change | 74.74% |
| Change since IPO | 509.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| QTS | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 0.05% | -9.9% | -2.0% |
| 1Y | 19.5% | -14.9% | -0.3% |
Return vs Industry: QTS exceeded the German Life Sciences industry which returned -14.9% over the past year.
Return vs Market: QTS exceeded the German Market which returned -0.3% over the past year.
Price Volatility
| QTS volatility | |
|---|---|
| QTS Average Weekly Movement | 4.6% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: QTS has not had significant price volatility in the past 3 months.
Volatility Over Time: QTS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 87,000 | Ari Bousbib | www.iqvia.com |
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
IQVIA Holdings Inc. Fundamentals Summary
| QTS fundamental statistics | |
|---|---|
| Market cap | €38.97b |
| Earnings (TTM) | €1.27b |
| Revenue (TTM) | €14.07b |
31.0x
P/E Ratio2.8x
P/S RatioIs QTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QTS income statement (TTM) | |
|---|---|
| Revenue | US$14.98b |
| Cost of Revenue | US$9.75b |
| Gross Profit | US$5.24b |
| Other Expenses | US$3.88b |
| Earnings | US$1.36b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 7.46 |
| Gross Margin | 34.96% |
| Net Profit Margin | 9.06% |
| Debt/Equity Ratio | 224.5% |
How did QTS perform over the long term?
See historical performance and comparison